Panacea Biotec Ltd News
Panacea Biotec up 9% on completing Phase III enrollment for DengiAll trial
In a year, Panacea Biotec shares have slipped around 15 per cent as compared to Sensex's rise of 8.7 per cent
 "Panacea Biotec up 9% on completing Phase III enrollment for DengiAll trial")
Panacea Biotec jumps nearly 14% as Unicef raises order size for 2026, 2027
Panacea Biotec share price was trading at over one-month high on Friday
 "Panacea Biotec jumps nearly 14% as Unicef raises order size for 2026, 2027")
Panacea Biotec to supply bivalent oral polio vaccines worth ₹127 cr to CMSS
Panacea Biotec Ltd on Thursday said it will supply bivalent oral polio vaccines worth Rs 127.2 crore to the Central Medical Services Society, Ministry of Health and Family Welfare. In a regulatory filing, Panacea Biotec said the Central Medical Services Society (CMSS) has accepted the company's offer for supply of bivalent oral polio vaccine against the tender issued by it through a Letter of Acceptance (LOA) dated October 8, 2025. "As per the LOA, the company will supply the vaccine worth Rs 127.2 crore in several tranches over a period of 90 - 480 days from the date of issuance of LOA," it added.
 "Panacea Biotec to supply bivalent oral polio vaccines worth ₹127 cr to CMSS")